-
The contribution of cerebrovascular risk factors, metabolic and inflammatory changes to cognitive decline in Parkinson’s disease
-
The contribution of striatal dopamine to feedforward motor control during gait initiation in Parkinson’s disease
-
The costs of caregiving in Parkinson’s disease
-
The development of a patient education and treatment programme for people with Parkinson’s disease
-
The differential role of subthalamic and nigral neurons in gait control in Parkinson´s disease patients
-
The distinct pattern of movement disorders in Caspr2 and LGI1 antibody associated autoimmune encephalitis
-
The dopamine receptor antagonist haloperidol enhances beta and gamma oscillations and bursts in the motor cortex
-
The Dutch Parkinson and Cognition study (DUPARC): Cognitive impairment and cholinergic innervation in de novo Parkinson’s Disease patients
-
The Dutch Parkinson and Microbiome Study (DUPARM): Gut Microbiome Composition of Treatment-Naïve De Novo Parkinson’s Disease Patients
-
The Dutch Yips Study
- « Previous Page
- 1
- …
- 189
- 190
- 191
- 192
- 193
- …
- 217
- Next Page »